Arecor Therapeutics PLC (GB:AREC) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Arecor Therapeutics PLC, a biopharmaceutical firm focused on enhancing therapies for healthier lives, has published its 2023 Annual Report and Accounts, with plans for an AGM on June 28, 2024, in London. These documents are now accessible for shareholders and interested parties on the company’s website. Arecor continues to develop its portfolio of proprietary products and partner with industry leaders to advance therapeutic products using its Arestat™ technology platform.
For further insights into GB:AREC stock, check out TipRanks’ Stock Analysis page.